Dopaminergic Differentiation of Human Embryonic Stem Cells on PA6-Derived Adipocytes.
(2016) In Methods in Molecular Biology 1341. p.235-244- Abstract
- Human embryonic stem cells (hESCs) are a promising source for cell replacement therapies. Parkinson's disease is one of the candidate diseases for the cell replacement therapy since the motor manifestations of the disease are associated with the loss of dopaminergic neurons in the substantia nigra pars compacta. Stromal cell-derived inducing activity (SDIA) is the most commonly used method for the dopaminergic differentiation of hESCs. This chapter describes a simple, reliable, and scalable dopaminergic induction method of hESCs using PA6-derived adipocytes. Coculturing hESCs with PA6-derived adipocytes markedly reduces the variable outcomes among experiments. Moreover, the colony differentiation step of this method can also be used for... (More)
- Human embryonic stem cells (hESCs) are a promising source for cell replacement therapies. Parkinson's disease is one of the candidate diseases for the cell replacement therapy since the motor manifestations of the disease are associated with the loss of dopaminergic neurons in the substantia nigra pars compacta. Stromal cell-derived inducing activity (SDIA) is the most commonly used method for the dopaminergic differentiation of hESCs. This chapter describes a simple, reliable, and scalable dopaminergic induction method of hESCs using PA6-derived adipocytes. Coculturing hESCs with PA6-derived adipocytes markedly reduces the variable outcomes among experiments. Moreover, the colony differentiation step of this method can also be used for the dopaminergic induction of mouse embryonic stem cells and NTERA2 cells as well. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5456843
- author
- Guloglu, Oktar LU and Larsen, Anna
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Methods in Molecular Biology
- volume
- 1341
- pages
- 235 - 244
- publisher
- Springer
- external identifiers
-
- pmid:25947418
- scopus:84950336383
- pmid:25947418
- ISSN
- 1940-6029
- DOI
- 10.1007/7651_2015_235
- language
- English
- LU publication?
- yes
- id
- 527ffde8-40c5-4c77-8de4-b9fa08b5776e (old id 5456843)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25947418?dopt=Abstract
- date added to LUP
- 2016-04-01 10:28:04
- date last changed
- 2022-01-25 23:31:51
@article{527ffde8-40c5-4c77-8de4-b9fa08b5776e, abstract = {{Human embryonic stem cells (hESCs) are a promising source for cell replacement therapies. Parkinson's disease is one of the candidate diseases for the cell replacement therapy since the motor manifestations of the disease are associated with the loss of dopaminergic neurons in the substantia nigra pars compacta. Stromal cell-derived inducing activity (SDIA) is the most commonly used method for the dopaminergic differentiation of hESCs. This chapter describes a simple, reliable, and scalable dopaminergic induction method of hESCs using PA6-derived adipocytes. Coculturing hESCs with PA6-derived adipocytes markedly reduces the variable outcomes among experiments. Moreover, the colony differentiation step of this method can also be used for the dopaminergic induction of mouse embryonic stem cells and NTERA2 cells as well.}}, author = {{Guloglu, Oktar and Larsen, Anna}}, issn = {{1940-6029}}, language = {{eng}}, pages = {{235--244}}, publisher = {{Springer}}, series = {{Methods in Molecular Biology}}, title = {{Dopaminergic Differentiation of Human Embryonic Stem Cells on PA6-Derived Adipocytes.}}, url = {{https://lup.lub.lu.se/search/files/1869417/8412071.pdf}}, doi = {{10.1007/7651_2015_235}}, volume = {{1341}}, year = {{2016}}, }